A detailed history of Everpar Advisors LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Everpar Advisors LLC holds 14,048 shares of MRK stock, worth $1.4 Million. This represents 0.83% of its overall portfolio holdings.

Number of Shares
14,048
Previous 15,547 9.64%
Holding current value
$1.4 Million
Previous $1.92 Billion 17.12%
% of portfolio
0.83%
Previous 0.96%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 07, 2024

SELL
$111.15 - $128.97 $166,613 - $193,326
-1,499 Reduced 9.64%
14,048 $1.6 Billion
Q2 2024

Jul 18, 2024

BUY
$123.8 - $132.96 $190,280 - $204,359
1,537 Added 10.97%
15,547 $1.92 Billion
Q1 2024

Apr 22, 2024

SELL
$113.24 - $131.95 $647,846 - $754,885
-5,721 Reduced 28.99%
14,010 $1.85 Billion
Q4 2023

Feb 06, 2024

BUY
$100.18 - $109.02 $1.98 Million - $2.15 Million
19,731 New
19,731 $2.15 Billion

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $253B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Everpar Advisors LLC Portfolio

Follow Everpar Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Everpar Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Everpar Advisors LLC with notifications on news.